MAS News

IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.

Over the past 3 months, 9 analysts have published their opinion on Masco (NYSE:MAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.